Regarding Mastorino et al.'s ‘Efficacy of anti‐IL‐23 and anti‐IL‐17 after adalimumab failure in psoriatic patients’-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Regarding Mastorino et al.'s ‘Efficacy of anti‐IL‐23 and anti‐IL‐17 after adalimumab failure in psoriatic patients’

Published:2023-07-26 Issue:12 Volume:37 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Yu Sebastian¹²^ORCID,Wei James Cheng‐Chung³⁴⁵

Affiliation:

1. Department of Dermatology, School of Medicine, College of Medicine Kaohsiung Medical University Kaohsiung Taiwan

2. Department of Dermatology Kaohsiung Medical University Hospital Kaohsiung Taiwan

3. Institute of Medicine Chung Shan Medical University Taichung Taiwan

4. Department of Allergy, Immunology & Rheumatology Chung Shan Medical University Hospital Taichung Taiwan

5. Graduate Institute of Integrated Medicine China Medical University Taichung Taiwan

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.19334

Reference10 articles.

1. Efficacy of anti‐IL‐23 and anti‐IL‐17 after adalimumab failure in psoriatic patients

2. Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial

3. Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis

4. Risk of chronic kidney disease and end-stage renal disease in patients with psoriasis: A systematic review and meta-analysis of cohort studies

5. Depression in psoriatic arthritis: Related to socio‐demographics, comorbid loads or disease activity?

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ‘Efficacy of anti‐IL‐23 and anti‐IL‐17 after adalimumab failure in psoriatic patients’—response to Yu et al.;Journal of the European Academy of Dermatology and Venereology;2023-09-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3